Expect to See More Quadruple Therapy for H. pylori
You'll see changes in preferred drug regimens for H. pylori.
Triple therapy with a PPI and two antibiotics (Prevpac, etc) will fall out of favor. It's not as reliable now that clarithromycin resistance exceeds 15% in many parts of North America.
Expect to see more use of QUADRUPLE therapy and regimens for 14 days instead of 7 to 10 days.